Volume 31, Issue 3 (Avicenna Journal of Clinical Medicine-Autumn 2024)                   Avicenna J Clin Med 2024, 31(3): 136-143 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ranjbaran F, Hosseintehrani M A, Shahmoradi Z, Nokani M, Sadeghi Sadeh B. Effect of Transcranial Direct Current Stimulation on Sertraline Composition on the Severity of Symptoms of Obsessive-Compulsive Disorder. Avicenna J Clin Med 2024; 31 (3) :136-143
URL: http://sjh.umsha.ac.ir/article-1-3079-en.html
Effect of Transcranial Direct Current Stimulation on Sertraline Composition on the Severity of Symptoms of Obsessive-Compulsive Disorder
Farideh Ranjbaran1 , Mohammad Ali Hosseintehrani 2, Zahra Shahmoradi1 , Mostafa Nokani1 , Bahman Sadeghi Sadeh3
1- Department of Psychiatry, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2- Department of Psychiatry, School of Medicine, Arak University of Medical Sciences, Arak, Iran , ahosseint@yahoo.com
3- Department of Community Medicine, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract:   (373 Views)
Background and Objective: One of the new treatment methods for obsessive-compulsive disorder (OCD) in patients who do not respond to the first line of drug treatment is brain stimulation from transcranial direct current stimulation (TDCS). However, there has been limited research regarding its effectiveness, with the results often being contradictory. In the present study, the effect of TDCS with sertraline drug on the severity of the disease and the improvement of various areas of obsessive thoughts and actions was investigated.
Materials and Methods: In this double-blind randomized clinical trial, 50 patients with OCD were randomly assigned to two groups of 25: an intervention group and a control group. The intervention group underwent active TDCS and the control group underwent passive TDCS each for 16 sessions (20 min per session). The intensity of OCD symptoms in both groups was evaluated using the Padua questionnaire at four time points: before treatment, 4 weeks after the start of treatment, 8 weeks after treatment initiation, and 1 month after the conclusion of the treatment.
Results: The two groups were similar in terms of age, gender, duration of illness, and severity of OCD before treatment (P<0.05). However, from the 8th and 16th sessions after the treatment, the overall score of OCD and its sub-domains in the intervention group was significantly lower than the control group (P<0.001).
Conclusion: In patients with OCD, TDCS as a non-invasive method during 8 and 16 sessions had a significant effect on the reduction of the symptoms related to OCD.
 
Keywords: Obsessive-Compulsive Disorder (OCD), Sertraline, Transcranial Direct Current Stimulation (TDCS)
Full-Text [PDF 1141 kb]   (180 Downloads)    
Type of Study: Original | Subject: Psychiatry
Extended Abstract [HTM 27 KB]  (48 Download)
References
1. Gillan CM, Fineberg NA, Robbins TW. A trans-diagnostic perspective on obsessive-compulsive disorder. Psychol Med. 2017;47(9):1528-48. PMID: 28343453 DOI: 10.1017/S0033291716002786
2. Salehi M, Salarifar MH, Hadian M. Frequency of patterns of obsessive-compulsive symptoms. 2004. Link
3. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry. 1997;58 (Suppl 12):7-10. PMID: 9393390
4. Franklin ME, Foa EB. Treatment of obsessive compulsive disorder. Annual review of clinical psychology. 2011;7:229-43. PMID: 21443448 DOI: 10.1146/annurev-clinpsy-032210-104533
5. Grant JE, Pinto A, Gunnip M, Mancebo MC, Eisen JL, Rasmussen SA. Sexual obsessions and clinical correlates in adults with obsessive-compulsive disorder. Compr Psychiatry. 2006;47(5):325-9. PMID: 16905392 DOI: 10.1016/j.comppsych.2006.01.007
6. Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol. 2004;65(3):185-236. PMID: 14757309 DOI: 10.1016/j.biopsycho.2003.07.007
7. Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730-9. PMID: 27318812 DOI: 10.1016/S2215-0366(16)30069-4
8. Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 2001;21(5):488-92. PMID: 11593074 DOI: 10.1097/00004714-200110000-00006
9. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry. 1995;56(8):368-73. PMID: 7635854
10. Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269-76. PMID: 16566623 DOI: 10.4088/jcp.v67n0214
11. Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, et al. Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5(2):181-91. PMID: 12135542 DOI: 10.1017/S1461145702002900
12. Rabinowitz I, Baruch Y, Barak Y. High-dose escitalopram for the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 2008;23(1):49-53. PMID: 18090508 DOI: 10.1097/YIC.0b013e3282f0f0c5
13. Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2009;70(6):863-8. PMID: 19422759 DOI: 10.4088/JCP.08m04369
14. Clark VP, Coffman BA, Trumbo MC, Gasparovic C. Transcranial direct current stimulation (tDCS) produces localized and specific alterations in neurochemistry: a ¹H magnetic resonance spectroscopy study. Neurosci Lett. 2011;500(1):67-71. DOI:10.1016/j.neulet.2011.05.244
15. Szymkowicz SM, McLaren ME, Suryadevara U, Woods AJ. Transcranial direct current stimulation use in the treatment of neuropsychiatric disorders: a brief review. Psychiatric annals. 2016;46(11):642-6. DOI:10.3928/00485713-20161006-01
16. Bation R, Poulet E, Haesebaert F, Saoud M, Brunelin J. Transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:153-7. PMID: 26439873 DOI: 10.1016/j.pnpbp.2015.10.001
17. D'Urso G, Brunoni AR, Mazzaferro MP, Anastasia A, de Bartolomeis A, Mantovani A. Transcranial direct current stimulation for obsessive-compulsive disorder: A randomized, controlled, partial crossover trial. Depress Anxiety. 2016;33(12):1132-1140. PMID: 27802585 DOI: 10.1002/da.22578
18. Dinn WM, Aycicegi-Dinn A, Göral F, Karamursel S, Yildirim EA, Hacioglu-Yildirim M, et al. Treatment-resistant obsessive-compulsive disorder: Insights from an open trial of transcranial direct current stimulation (tDCS) to design a RCT. Neurology, Psychiatry and Brain Research. 2016;22(3-4):146-54. DOI:10.1016/j.npbr.2016.08.003
19. Silva R, Brunoni AR, Goerigk S, Batistuzzo MC, Costa D, Diniz JB, et al. Efficacy and safety of transcranial direct current stimulation as an add-on treatment for obsessive-compulsive disorder: a randomized, sham-controlled trial.Neuropsychopharmacology. 2021;46(5):1028-34. PMID: 33452434 DOI: 10.1038/s41386-020-00928-w
20. Kumar S, Kumar N, Verma R. Safety and efficacy of adjunctive transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label trial. Indian J Psychiatry. 2019;61(4):327-34. PMID: 31391634 DOI: 10.4103/psychiatry.IndianJPsychiatry_509_18
21. D'Urso G, Brunoni AR, Anastasia A, Micillo M, de Bartolomeis A, Mantovani A. Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder. Neurocase. 2016;22(1):60-4. PMID: 25971992 DOI: 10.1080/13554794.2015.1045522
22. Harika-Germaneau G, Heit D, Chatard A, Thirioux B, Langbour N, Jaafari N. Treating refractory obsessive-compulsive disorder with transcranial direct current stimulation: An open label study. Brain Behav. 2020;10(7):e01648. PMID: 32406608 DOI: 10.1002/brb3.1648
23. Gowda SM, Narayanaswamy JC, Hazari N, Bose A, Chhabra H, Balachander S, et al. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial. Brain Stimul. 2019;12(4):922-9. PMID: 30808612 DOI: 10.1016/j.brs.2019.02.005
24. Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA psychiatry. 2013;70(4):383-91. PMID: 23389323 DOI: 10.1001/2013.jamapsychiatry.32
25. Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, et al. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. N Engl J Med. 2017;376(26):2523-33. PMID: 28657871 DOI: 10.1056/NEJMoa1612999
26. Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5(1):52. PMID: 31371720 DOI: 10.1038/s41572-019-0102-3
27. Rapinesi C, Kotzalidis GD, Ferracuti S, Sani G, Girardi P, Del Casale A. Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review. Curr Neuropharmacol. 2019;17(8):787-807. PMID: 30963971 DOI: 10.2174/1570159X17666190409142555
28. André S, Heinrich S, Kayser F, Menzler K, Kesselring J, Khader PH, et al. At-home tDCS of the left dorsolateral prefrontal cortex improves visual short-term memory in mild vascular dementia. J Neurol Sci. 2016;369:185-90. DOI: 10.1016/j.jns.2016.07.065
29. Hogeveen J, Grafman J, Aboseria M, David A, Bikson M, Hauner KK. Effects of High-Definition and Conventional tDCS on Response Inhibition. Brain Stimul. 2016;9(5):720-9. PMID: 27198577 DOI: 10.1016/j.brs.2016.04.015
30. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65-94. PMID: 9000892 DOI: 10.1037/0033-2909.121.1.65
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb